A phase 2 clinical trial has demonstrated that bimagrumab, when combined with semaglutide, resulted in significant weight loss for trial participants while maintaining lean muscle mass suggesting a promising approach for Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial The Lancet Frontiers The role of GIPR in food intake control Remission of type 2 diabetes: position statement of the Italian society of diabetes (SID) Acta Diabetologica Springer Nature Link